Graves Disease Clinical Trials in Torrance, California

3 studies are recruiting for graves disease in Torrance, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

    This study is being conducted to look at the effect YB-101 has on thyroid function. This study will also evaluate how safe and well tolerated YB-101 is and how it is distributed through the body. The study consists of a part 1, blinded treatment period, and a part 2 double-blinded treatment period.…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Site 105, Torrance, California
    Locations
    29 in total
    Run by
    Yarrow Bioscience, Inc.

    See if you can join NCT07682896 on ClinicalTrials.gov

  2. NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

    The purpose of this study is to evaluate how well MER511 is tolerated and what side effects may occur in adults who have Graves' disease. The study drug will be administered either intravenously (into a vein in the arm) or subcutaneously (under the skin). Blood tests will be performed to investigat…

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Site # 1111, Torrance, California
    Locations
    16 in total
    Run by
    Merida Biosciences

    See if you can join NCT07305818 on ClinicalTrials.gov

  3. A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

    This is a study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment. The primary objective of this study is to evaluate the efficacy of IMVT-1402 versus placebo as assessed by T3 …

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Site Number - 1005, Torrance, California
    Locations
    134 in total
    Run by
    Immunovant Sciences GmbH

    See if you can join NCT06727604 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.